Cargando…
Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing
Spirochetal pathogens, such as the causative agent of Lyme disease, Borrelia burgdorferi sensu lato, encode an abundance of lipoproteins; however, due in part to their evolutionary distance from more well-studied bacteria, such as Proteobacteria and Firmicutes, few spirochetal lipoproteins have assi...
Autores principales: | Pereira, Michael J., Wager, Beau, Garrigues, Ryan J., Gerlach, Eva, Quinn, Joshua D., Dowdell, Alexander S., Osburne, Marcia S., Zückert, Wolfram R., Kraiczy, Peter, Garcia, Brandon L., Leong, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060444/ https://www.ncbi.nlm.nih.gov/pubmed/35312359 http://dx.doi.org/10.1073/pnas.2117770119 |
Ejemplares similares
-
Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study
por: Li, Danni, et al.
Publicado: (2018) -
Hide and Seek: How Lyme Disease Spirochetes Overcome Complement Attack
por: Kraiczy, Peter
Publicado: (2016) -
Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s
por: Garrigues, Ryan J., et al.
Publicado: (2022) -
Travelling between Two Worlds: Complement as a Gatekeeper for an Expanded Host Range of Lyme Disease Spirochetes
por: Kraiczy, Peter
Publicado: (2016) -
Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes
por: Xie, Jialei, et al.
Publicado: (2019)